The Discounted Cash Flow (DCF) valuation of Chinook Therapeutics Inc (KDNY) is (71.50) USD. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on DCF is -277.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.2% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (148.90) - (47.84) | (71.50) |
| Upside | -468.7% - -218.4% | -277.0% |